INVIVO THERAPEUTICS HOLDINGS CORP.: going-concern / distress — InVivo Therapeutics files Chapter 11 bankruptcy, seeks asset sale

INVIVO THERAPEUTICS HOLDINGS CORP.

Filed voluntary Chapter 11 petitions on Feb 1, 2024 in Delaware Bankruptcy Court.
Will operate as debtor-in-possession; filed motions for continued business practices and potential asset sale.
Case administered under 'In re InVivo Therapeutics Holdings Corp., et al.'; claims agent is Kurtzman Carson Consultants.

Key facts

Extracted from this filing and checked against the source text.

Distress & Bankruptcy SEC 8-K Item 1.03 confidence 0.9

INVIVO THERAPEUTICS HOLDINGS CORP. entered chapter 11 in United States Bankruptcy Court for the District of Delaware (petition 2024-02-01).

Proceeding: chapter 11
Court: United States Bankruptcy Court for the District of Delaware
Petition: 2024-02-01

Exact text from the filing

On February 1, 2024, after considering all strategic alternatives, InVivo Therapeutics Holdings Corp. and its subsidiary InVivo Therapeutics Corporation (together, the “Company”) filed voluntary petitions (the “Voluntary Petitions”) for relief under the provisions of Chapter 11 of Title 11 of the United States Code (the “Code”) in the United States Bankruptcy Court for the District of Delaware (the “Court”).

View on SEC.gov

Browse all distress & bankruptcy →

Source: SEC EDGAR

accession 0001104659-24-009146

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.